NCT04935411View on ClinicalTrials.gov

Russian Registry of Patients With nAMD

TerminatedOBSERVATIONAL
Enrollment

2,665

Participants

Timeline

Start Date

December 20, 2020

Primary Completion Date

December 5, 2022

Study Completion Date

December 5, 2022

Conditions
Neovascular Age-Related Macular Degeneration
Interventions
OTHER

nAMD

patients diagnosed with Neovascular Age-Related Macular Degeneration

Trial Locations (1)

630087

Novartis Investigative Site, Novosibirsk

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY